The findings suggest a dynamic relationship between MYC amplification and innate immune suppression in MYC amplified neoplasms and support further investigation of phagocytosis modulation as a strategy to enhance cancer immunotherapy responses. MES was fortunate to collaborate with the study leads Marc Remke from Düsseldorf, Germany and Siddhartha Mitra from Colorado, USA. See the paper published in J Immunother Cancer.